Morales 1988.
| Methods | Randomised clinical trial. All women received betamethasone. |
|
| Participants | 92 women at less than 33 weeks' gestation. Not eligible if intrauterine growth restriction, known congenital abnormalities, or maternal bleeding disorder. | |
| Interventions | 10 mg vitamin K intramuscularly every 5 days until delivery (n = 46). Control group (n = 46) given no treatment. | |
| Outcomes | IVH assessed by cranial ultrasound 24 and 72 hours after birth reviewed by a radiologist blinded to treatment. Other neonatal morbidity including respiratory distress syndrome. Cord blood clotting profiles. | |
| Notes | No sample size estimation reported. All babies with any respiratory distress syndrome received mechanical ventilation. | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Adequate sequence generation? | Unclear risk | Not reported by authors. |
| Allocation concealment? | Unclear risk | Allocation by sealed envelopes. Not reported if the envelopes were sequentially numbered or opaque. |
| Blinding? All outcomes | High risk | No placebo used, however, assessment of the primary outcome was blinded. |
| Incomplete outcome data addressed? All outcomes | Unclear risk | Losses to follow up not reported. |
| Free of selective reporting? | Low risk | No indication of selective reporting. |
| Free of other bias? | Unclear risk | Unclear. |